World Scientific
Skip main navigation

Cookies Notification

We use cookies on this site to enhance your user experience. By continuing to browse the site, you consent to the use of our cookies. Learn More
×

System Upgrade on Tue, May 28th, 2024 at 2am (EDT)

Existing users will be able to log into the site and access content. However, E-commerce and registration of new users may not be available for up to 12 hours.
For online purchase, please visit us again. Contact us at customercare@wspc.com for any enquiries.
https://doi.org/10.1142/9781786344946_0022Cited by:0 (Source: Crossref)
Abstract:

The following sections are included:

  • Deep vein thrombosis (DVT) and pulmonary embolism (PE) are the leading causes of preventable in-patient mortality following surgery.

  • Many DVTs are asymptomatic, but are still a risk for PE.

  • Validated clinical prediction rules should be used to estimate the pretest probability of venous thromboembolism (VTE), e.g., Wells score.

  • D-dimer level measurements are useful screening tests.

  • Ultrasonography is the current first-line imaging investigation for DVT.

  • Newer anticoagulants such as rivaroxaban and dabigatran are now being used for prophylaxis and treatment of VTE.

  • Inferior vena caval filters (IVCFs) should be used when anticoagulation is contraindicated or further VTE occurs despite adequate anticoagulation.

  • DVT can lead to post-thrombotic syndrome (PTS) in the longer term.

  • Thrombolysis should be considered in younger, fitter patients with ileofemoral DVT to reduce PTS risk.